In February, Federal Health Minister Greg Hunt boasted that AstraZeneca’s COVID-19 vaccine offered “100% protection” against death in the primary analysis of phase III trials.
It was repeated by the CEO of AstraZeneca and uncritically reported by the mainstream media in what seemed to be an impressive achievement.
The published study in The Lancet, however, revealed a more nuanced picture.